News und Analysen
3 Dividend Stocks That Still Make Sense in 2023
It was hard to find big stock market winners in 2022. But dividend stocks were among the better performers. Dividend-paying stocks give investors a reward for simply holding on to the stock. That
United Health Stock Is Flying, It May Only Be The Beginning
The United States Economy is beginning to undergo a significant pivot, where specific industries will be rewarded with investment inflows over others. As the FED attempts to combat rampant inflation
Investors Like Adobe's Potential To Leverage Generative AI
A few decades ago, a comedian named Murray Langston made a splash with an alter ego he dubbed “the unknown comic.” Langson was funny, but nobody knew who he was, since he performed with a bag over
Eilt: 20% der Hautkrebs-Patienten vollständig geheilt - Massives Kaufsignal. Neuer 204% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB).
20% der Hautkrebs-Patienten vollständig geheilt - Massives Kaufsignal. 204% Biotech Hot Stock nach 134.452% mit Biogen
17.07.23 08:03
London (www.aktiencheck.de , Anzeige)
Investing in Blue Chip Stocks: A Guide to Stability and Growth
Investors who are looking for stability and steady growth often turn toward blue chip stocks. Blue chip stocks are shares in large, well-established companies with a history of reliable performance
Wells Fargo's Earnings, Why Markets Are Loving The Stock
The SPDR S&P 500 ETF Trust (NYSEARCA: SPY) has been trading within a tight channel during the past year, hovering between the $420 and $375 per share marks. This trading range could be seen as
Citigroup Leads Banking Earnings, What's Next?
Not too long ago, commercial and investment banks passed the annual FED 'stress test,' where banks are under the heat of liquidity and leverage scrutiny. The leading United States firms passed
BlackRock Kicks Off Financials Earnings Season, Gauge To Markets
A new earnings season is beginning to kick off, bringing on periods of increased volatility and opportunity to investors as long as they position themselves within the favored industries and names
JPMorgan Chase Is In Reversal But Don’t Chase It Higher
The price action in JPMorgan Chase & Company (NYSE: JPM) has been bullish all year. The prospect of higher interest rates, widening margins, and increased earnings have helped to drive the market
Fastenal Falls To The Buy Zone: But Wait To Buy More
Fastenal (NASDAQ: FAST) fell following its Q2 earnings release and could fall further. The caveat is that tepid results do not overshadow the company’s strengths, including a solid balance sheet
Broadcom Emerges As Strong Contender For Generative AI Chips
So far in the AI gold rush, Nvidia Corp. (NASDAQ: NVDA) has emerged as the leading chipmaker. However, analysts and investors are beginning to notice the potential for Broadcom Inc. (NASDAQ: AVGO)
Analysts Are Recommending Symbiotic In July, High Potential?
Every market turn, such as the one investors encounter today, brings to light a set of favorite industries with their own set of perceived 'winning' stocks. The larger the underlying pivot, the
Will Cintas Scale a New High in 2023?
Despite its already-high valuation, Cintas (NASDAQ: CTAS) can scale new highs in 2023. Its FQ4 results and guidance confirm the business trajectory's growing and widening margin.
As highly
Eilt: Hautkrebs-Studie mit sensationellen Ergebnissen - Massives Kaufsignal. Neuer 204% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Hautkrebs-Studie mit sensationellen Ergebnissen - Massives Kaufsignal. 204% Biotech Aktientip nach 15.973% mit BioNTech
14.07.23 08:02
London (www.aktiencheck.de , Anzeige)
Despite Breaking Higher, Analysts Remain Cautious HP Inc.
The computer and office equipment giant HP Inc. (NYSE: HPQ) has been trading steadily higher this year, with the stock up over 22%. Shares of HPQ recently broke above a critical level of
PepsiCo Can Soar To New Highs In The 2nd Half
PepsiCo (NASDAQ: PEP) has been leading the beverage and consumer staples market for years, and the company is unlikely to lose its position. The Q2 results prove the pep+ strategy is working and
Motorola Approaches Buy Point As Analysts Boost Price Targets
S&P 500 component Motorola Solutions Inc. (NYSE: MSI) is within 1% of a buy point, getting a boost on July 12 along with the broader market.
A look at the Motorola Solutions chart shows the
3 Hotel Stocks Earning Five Star Ratings From Markets In July
Markets can have their pick-and-choose cycles for their favored sectors in the economy. The hotel and accommodation spaces are among the few sectors pushing the U.S. economy forward, despite FED
3 Biotech Stocks to Buy for Long-Term Gains
Suppose you’re looking for a sector that will benefit from an end to the Federal Reserve’s interest rate hiking campaign. In that case, you may look at biotech stocks, a sector filled with
Netflix Can Soar Higher In The 2nd Half
Netflix (NASDAQ: NFLX) made some big changes over the last year, but the signs are good that those changes are working for the better. The combination of password-sharing initiatives and
Sensationeller Erfolg im Kampf gegen Hautkrebs - Massives Kaufsignal. Neuer 206% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 206% mit Biotech Hot Stock
Sensationeller Erfolg im Kampf gegen Hautkrebs - Massives Kaufsignal. 206% Biotech Aktientip nach 134.452% mit Biogen
13.07.23 08:18
London (www.aktiencheck.de, Anzeige)
This Small Cap Stock Surged Over 100%
Arguably the most impressive mover yesterday was a stock you have probably never heard of. Shares of Eloxx Pharmaceuticals (NASDAQ: ELOX) rocketed almost 100% yesterday after receiving an
Activision Surges 10% As Judge OK's Microsoft Acquisition Deal
Activision Blizzard Inc. (NASDAQ: ATVI) shares rose to the call of duty on July 11, advancing 10.02% in heavy trading volume as a federal judge gave the OK for Microsoft Corp. (NASDAQ: MSFT) to
Erstklassige Studienergebnisse im Kampf gegen Hautkrebs - Massives Kaufsignal. Neuer 208% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Erstkl. Studienergebnisse im Kampf gegen Hautkrebs - Massives Kaufsignal. 208% Biotech Hot Stock nach 31.205% mit Amgen
12.07.23 08:02
London (www.aktiencheck.de, Anzeige)
Could CAVA Be The Next Chipotle? Here's How Close It Gets
The United States IPO (Initial Public Offering) market had been on a dry spell during the past few months due to more challenging than average financing rates and hurdles, aided by a FED acting to